• SENSEX 78,890.97
    1,589.57 (+2.06%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,850.00 1,878.00(%)
  • ITC
    277.30 252.80(%)
  • Tube Investments
    2,227.65 2,006.00(%)
  • Axis Bank
    1,274.00 1,418.30(%)
  • Reliance Industries
    1,325.00 1,611.20(%)
  • HDFC Life Insur.
    546.00 788.50(%)
  • Aurobindo Pharma
    1,748.85 1,739.95(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Titan Company
    4,858.90 5,187.45(%)
  • Petronet LNG
    320.00 326.40(%)
  • CG Power & Ind
    812.40 525.50(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • Saregama India
    613.80 305.65(%)
  • Multi Comm. Exc.
    3,395.00 3,537.00(%)
  • Tonbo Imaging
    1,460.00 1,343.80(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Bajaj Finance
    1,053.90 1,177.60(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Bajaj Auto
    10,750.10 12,470.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bliss GVS Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 79.0
  • ISIN : INE416D01022
619.55 -12 (-1.86%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    601.00

  • Today’s High

    637.00

  • Open

    637.00

  • Perv Close

    631.30

  • 52W Low

    118.00

  • 52W High

    739.90

Key Indicators

  • P/E(TTM)

    49.69

  • Mar.Cap (₹Cr.)

    6,591.02

  • Div & Yield %

    0.16

  • Book Value(₹)

    118.99

  • Debt-Equity Ratio

    -1.86

  • AGM Date

    04-Nov-2026

  • EPS

    12.59

  • P/E Ratio

    49.69

Financials Ratios

  • Debt-Equity Ratio

    0.11

  • Mar.Cap (₹Cr.)

    6,591.02

  • RONW (%)

    11.02

  • ROCE (%)

    14.84

Score Board

  • Equity (₹ in Cr.)

    10.64

  • BV (₹)

    119.00

  • Sales( ₹ in Cr.)

    729.81

  • NP (in Cr.)

    98.13

  • NP Var(%)

    42.0

  • Div%

    100.0

  • CPS (₹)

    12.10

  • EPS (₹)

    9.20

  • Traded Value (₹ in Lakhs)

    6,655.38

  • 52 Week High

    739.90

  • 52 Week Low

    118.00

  • Price BSE

    626.0

  • Price NSE

    620.00

  • Market Capital( in Cr.)

    6,655.38

  • P/C Ratio

    51.60

  • P/E Ratio

    67.90

  • Price Vs.BV

    9.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 729.81 667.20 605.46 598.34 636.36 465.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 729.81 667.20 605.46 598.34 636.36 465.51
Other Income 43.72 36.22 33.50 50.77 35.37 17.68
Stock Adjustments 25.62 -6.63 6.36 -21.24 8.90 8.85
Total Income 799.15 696.79 645.32 627.87 680.63 492.04
EXPENDITURE :            
Raw Materials 368.25 339.47 305.83 293.66 352.84 262.15
Power and Fuel Cost 12.95 9.76 8.81 5.80 7.09 6.99
Employee Cost 121.50 99.42 82.59 72.54 65.06 58.61
Other Manufacturing Expenses 20.05 15.50 17.25 11.57 11.54 7.49
Selling and Administration Expenses 79.30 78.23 66.73 66.90 67.07 36.90
Miscellaneous Expenses 21.50 26.61 64.52 36.48 32.45 10.76
Employee Benefit Expenses 121.50 99.42 82.59 72.54 65.06 58.61
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 623.54 568.98 545.74 486.95 536.05 382.90
Operating Profit 175.59 127.80 99.59 140.93 144.57 109.14
Interest 11.11 6.58 5.81 10.06 4.32 4.19
Gross Profit 164.48 121.22 93.78 130.87 140.25 104.95
Depreciation 31.02 27.05 23.52 15.17 13.85 13.76
Profit Before Tax 133.46 94.17 70.26 115.70 126.40 91.19
Current Tax 42.54 29.99 26.34 34.42 31.92 21.52
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -5.95 -4.79 -6.72 -4.21 1.81 2.16
Reported Net Profit 96.87 68.97 50.64 85.48 92.66 67.50
Extraordinary Items -1.25 -0.14 -25.47 0.26 2.09 -0.02
Adjusted Net Profit 98.12 69.11 76.11 85.22 90.57 67.52
Adjustment below Net Profit -0.18 -0.56 -0.15 -0.67 0.30 0.52
P & L Balance brought forward 956.86 892.57 846.18 765.33 676.22 613.36
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 9.91 4.12 4.10 3.97 3.86 5.16
P & L Balance carried down 1,043.65 956.86 892.57 846.18 765.33 676.22
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 50.00 50.00 50.00 50.00 50.00
Dividend Per Share(Rs) 0.10 0.50 0.50 0.50 0.50 0.50
Earnings Per Share-Unit Curr 9.16 6.55 4.84 8.21 8.94 6.54
Earnings Per Share(Adj)-Unit Curr 9.16 6.55 4.84 8.21 8.94 6.54
Book Value 109.20 100.47 94.41 89.96 82.12 73.26
Book Value(Adj)-Unit Curr 109.20 100.47 94.41 89.96 82.12 73.26

Shareholding Pattern

  • Promoter Group

    50.07%

  • Public Share Holding

    49.93%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,251,669 2.12 2,251,669 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 50,984,595 47.95 50,984,595 1
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 53,236,264 50.07 53,236,264 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 1,891 0.00 1,891 1
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,345,491 5.03 5,345,491 48
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,624,317 1.53 1,624,317 1
Mutual Funds / UTI 2,699 0.00 2,699 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 8,605,147 8.09 8,605,147 15
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 15,579,545 14.65 15,579,545 67
2] Non Institution
Bodies Corporate 5,332,695 5.02 5,307,295 360
Clearing Members 333,354 0.31 333,354 41
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,158,868 1.09 1,088,268 915
Foreign Non Institution Other 200 0.00 200 1
Hindu Undivided Families 2,356,562 2.22 2,356,562 909
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,813,145 3.59 3,813,145 9
Individuals holding nominal share capital up to Rs. 1 lakh 20,615,513 19.39 19,534,411 45,595
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 34,193 0.03 34,193 4
Others 2,657,917 2.50 2,657,917 3
Sub Total 37,514,663 35.28 36,337,561 47,875
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 106,330,472 100.00 105,153,370 47,944

Company Background

Bliss GVS Pharma LtdPharmaceuticals - Indian - Formulations

  • Bliss GVS Pharma Ltd
  • BSE Code : 79.0
  • ISIN : INE416D01022

  • Incorporation Year

    1984

  • Registered Office

    102 Hyde Park Sakivihar Road
    Andheri East, Mumbai,
    Maharashtra-400072

  • Telephone

    91-22-42160000

  • FAX

    91-22-28563930

  • Chairman

    Nandkumar Kashinath Chodankar

  • Managing Director

  • Company Secretary

    Aditi Bhatt

  • Auditor

    Kalyaniwalla & Mistry LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Bliss GVS Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Sanofi India 3,450.75 1,857.10 1,837.40 21.80 54.17
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77